Hepatic miR-29ab1 expression modulates chronic hepatic injury.
about
Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASHSystemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated MiceThe roles of microRNA families in hepatic fibrosis.Exploiting microRNA regulation for genetic engineering.Social isolation impairs oral palatal wound healing in sprague-dawley rats: a role for miR-29 and miR-203 via VEGF suppression.FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling.Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature.Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.Pathophysiological role of microRNA-29 in pancreatic cancer stromaMolecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the PromoterMicroRNAs in Liver Health and DiseasemicroRNAs in liver disease: from diagnostics to therapeutics.Apoptosis and necrosis in the liverRole of microRNA machinery in kidney fibrosis.Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathwayIn vitro molecular study of wound healing using biosynthesized bacteria nanocellulose/silver nanocomposite assisted by bioinformatics databasesTissue-specific effects of targeted mutation of Mir29b1 in rats
P2860
Q26778376-78FCEBAE-6785-4F29-BE14-EF2835CBD798Q28546811-60EB4089-3F4A-4AE4-A671-8A0069D6AECAQ33868794-6A9C3A05-5D74-4D9F-A859-EB6500C09E02Q34302499-34359E07-406A-4B06-9B9A-0A14AC377E3EQ34951617-E38CBFA2-54BF-4840-A25A-19A502CB83F8Q35551588-C497CE8E-57CB-4FFC-B6C9-AA459C8C4EC6Q35644474-CCF3FEF6-8157-4742-80C9-8BA6AFFA3E0DQ35754727-D88669E5-0798-47D1-8A4B-B6D94492982EQ35765000-555CFBB6-B7E9-42EE-ACF7-49B2FA024061Q35833292-BD939C1B-EC61-40A5-807A-4A3E2E238952Q36739805-DAC29289-736E-4D87-9E5E-9A8AF6677884Q37246198-37EF1973-8219-4E9E-ADAB-30826039837DQ37403072-56A6DF93-6CBB-411B-8329-5DE1C595DE7EQ38209551-AC343747-0964-4FA9-90F7-8596BC56F58FQ41886234-80277208-6298-4700-8DA5-4CBCACCE6FBAQ57154331-DCB51214-419E-4A93-A7CD-3D7A46C47905Q58746606-4800182B-6A50-4422-8B2F-8CF325364A82Q58779657-BFAE09FA-CB6D-484D-89F6-58350E26906C
P2860
Hepatic miR-29ab1 expression modulates chronic hepatic injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Hepatic miR-29ab1 expression modulates chronic hepatic injury.
@en
Hepatic miR-29ab1 expression modulates chronic hepatic injury.
@nl
type
label
Hepatic miR-29ab1 expression modulates chronic hepatic injury.
@en
Hepatic miR-29ab1 expression modulates chronic hepatic injury.
@nl
prefLabel
Hepatic miR-29ab1 expression modulates chronic hepatic injury.
@en
Hepatic miR-29ab1 expression modulates chronic hepatic injury.
@nl
P2093
P2860
P1476
Hepatic miR-29ab1 expression modulates chronic hepatic injury.
@en
P2093
Chiara Braconi
Stefan Costinean
Takayuki Kogure
Tushar Patel
P2860
P304
P356
10.1111/J.1582-4934.2012.01578.X
P577
2012-11-01T00:00:00Z